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Abstract
Hypoxic-ischemic encephalopathy (HIE) is the most important cause of cerebral damage and long-term neurologi-
cal sequelae in the perinatal period both in term and preterm infant.
Hypoxic-ischemic (H-I) injuries develop in two phases: the ischemic phase, dominated by necrotic processes, and
the reperfusion phase, dominated by apoptotic processes extending beyond ischemic areas. Due to selective
ischemic vulnerability, cerebral damage affects gray matter in term newborns and white matter in preterm
newborns with the typical neuropathological aspects of laminar cortical necrosis in the former and periventricular
leukomalacia in the latter.
This article summarises the principal physiopathological and biochemical processes leading to necrosis and/or
apoptosis of neuronal and glial cells and reports recent insights into some endogenous and exogenous cellular
and molecular mechanisms aimed at repairing H-I cerebral damage.
Introduction
Hypoxic-ischemic encephalopathy (HIE) is the most
important cause of cerebral damage and long-term neu-
rological sequelae in the perinatal period both in term
and preterm infant [1].
Until few years ago, the main acquisitions on the
physiopathogenetic mechanisms of this affection came
from experimental studies on animals. Recently, the
progress in brain immunocytochemistry, the discovery
of specific neuropathologic biochemical markers and,
above all, the development of new and sophisticated
techniques of nuclear magnetic resonance (NMR), i.e.
diffusion weighted imaging (DWI), diffusion tensor
immaging (DTI), tractography (Fibre-Tracking Techni-
ques) and magnetic resonance spectroscopy (MRS),
have collected data directly from human infants [2].
Physiopathology
Besides the main role of perinatal asphyxia, a key factor
in the genesis of HIE is the loss of “cerebral blood flow
(CBF) autoregulation”, a protective mechanism that
maintains stable cerebral blood flow velocity (CBFV) in
normal infants, regardless of variations of systemic
arterial pressure. This mechanism is expressed by reflex
modifications of cerebral arteriolar tone induced by
secretion of some humoral factors with vasoconstrictive
or vasodilatative action. In case of rising pressure, the
release of vasoconstrictors (such as endothelin and
thromboxane) that increases arteriolar resistances,
reduces CBFV, while in the event of low pressure the
release of vasodilators (such as prostacicline and nitric
oxide) reduces arterioral resistances and increases CBFV
[3]. It has to be underlined that these autoregulator
mechanisms are functionally immature in preterm
infants and can be jeopardised by perinatal asphyxia
due to vasoparalysis induced by increased PaCO2 and
acidosis [4].
In presence of impaired autoregulation, CBF becomes
passive to pressure stimuli. In this way, rising pressure
increases CBF and can cause haemorrhagic phenomena,
while low pressure reduces CBF and can cause ischemic
phenomena. It has to be kept in mind that systemic
arterial hypotension is frequent in high-degree prema-
ture infants who present cardiac contractile function
and sympathetic vascular tone immaturity, and in all
newborns with perinatal asphyxia, resulting from
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and acidosis [5]. This explains why these infants are par-
ticularly exposed to cerebral ischemia.
Ischemia reduces CBF and thus supplies less oxygen
and fewer nutrients (especially glucose, fundamental for
brain energetic metabolism) and this in turn induces
neural and glial cells distress triggering off cerebral
damage. This is prevalently necrotic damage in cases of
severe asphyxia and apoptotic in moderate asphyxia [6].
The severity and extension of brain damage are strictly
related to intensity, timing and duration of hypoxic-
ischemic (H-I) insult. The more intense and long-lasting
it is, the greater is the number of neuronal and glial
cells which die.
Mechanisms of cerebral injury
Numerous studies show that H-I cerebral damage
develops in two phases: the first or “ischemic phase”
dominated by necrotic processes in the ischemic areas
and the second or “reperfusion phase” dominated by
apoptotic processes extending beyond ischemic areas.
This second phase takes place two - six hours after
H-I insult, such latency constituting a useful window
in which therapeutic measures can be able to stop the
evolution of cerebral damage [6,7].
Ischemic phase
In this phase, the crucial event triggering a cascade of
chain reactions is represented by ATP depletion second-
ary to anaerobic glycolysis and metabolic acidosis
induced by hypoxia [8]. Reduced ATP availability deter-
mines the dysfunction of ATPase systems, in particular
Na
+,K
+-ATPase and glial-ATPase. Na
+,K
+-ATPase dys-
function determines depolarization of neurons causing
intracellular sodium and water accumulation with cyto-
toxic edema and/or cell lysis followed by inflammatory
reaction with cytokines release. At the same time, neu-
ronal depolarization induces delivery of glutamate (a
neuroexcitatory aminoacid) which tends to accumulate
in the intersynaptic and intercellular spaces because of
the dysfunction of glial-ATPase, an astrocytic enzyme
normally delegated to its reuptake. Glutamate stimulates
specific NMDA and AMPA neuro-glial receptors and
hence determines a massive intracellular entry of cal-
cium that activates some endocellular enzymes including
protease and phospholipase. Protease degrades neurofi-
laments and can determine cytoskeleton rupture with
disintegration of the cellular body; phospholipase hydro-
lyzes phospholipids and can damage cellular membrane
and induce the release of arachidonic acid with conse-
quent production of vasodilator prostaglandins that give
rise to reperfusion of ischemia (Figure 1). Furthermore,
excessive amounts of glutamate can cause excitotoxicity
leading to the death of neurons and glial cells [8].
Reperfusion phase
In this phase, recovery of ischemia increases O2 avail-
ability and hence activates xantine-oxidase and ciclo-
oxygenase enzymes and generates reactive oxygen
species (ROS) responsible for oxidative cellular damage
[9]. The formation of free-radicals, some being highly
reactive such as hydroxyl radical, in addition to oxygen
is also supported by a major haematic concentration
of free iron due to hypoxia-induced acidosis that is
known to detach the iron bonded in circle to transferr-
i n e[ 1 0 ] .T h e s eo x i d a t i v ep r o c e s s e s ,i nf a c t ,c a n
be blocked by deferoxamine, an iron-chelator that
experimental studies in lambs have shown capable of
preserving cortical cells membrane stability and elec-
trocortical brain activity when used during early reper-
fusion after H-I insult [11]. Free radicals determine
various harmful reactions. They can induce deep
alterations in cellular ultrastructure through membrane
lipids peroxidation and ionic channels dysfunction.
At same time, by damaging endothelial tight-junctions,
they disrupt the blood-brain barrier (BBB) integrity
causing an interstitial-vasogenic edema which worsens
cerebral damage. Another dangerous biochemical
action of free radicals is the activation of endothelial
cells that induce adhesins and chemokines releases and
thus can determine endoarteriolar accumulation of
neutrophiles and platelets with alteration of CBF lead-
ing to secondary ischemic necrosis (Figure 2). Other
biochemical injuries caused by free radicals are those
connected to the development of apoptosis. This can
be due to activation of caspases enzymatic system
resulting from cytochrome C release secondary to oxi-
dative mitochondrial damage, and to induction of
proapoptotic genes, i.e. Bax-gene [12]. Studies on the
cortical tissue of rat pups exposed to 100% O2 after
neonatal H-I insult have shown that hyperoxia deter-
mines an early increase in intranuclear and total
nuclear Bax protein levels followed by subsequent Bax
redistribution to the mitochondria and endoplasmic
reticulum with activation of biochemical signals indu-
cing apoptosis and inflammation [13]. Oxygen concen-
tration during resuscitation must be reduced to
prevent these dangerous effects. During cerebral ische-
mia reperfusion, increased production of nitric oxide,
due to neural and endothelial nitric oxide-synthetase
activation, can cause further damages. In the first case,
the intraparenchimal release of nitric oxide interacts
with hydroxyl radical and leads to the formation
of peroxynitrite, a highly cytotoxic agent for cerebral
tissues. In the second case, endovasal release of nitric
oxide causes vasodilatation with increased endothelial
permeability and facilitates intracerebral diffusion of
cytokines and reactive molecules that contribute to the
development of neuronal and glial cells damage [14].
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The location of cerebral damage differs depending on
gestational age and involves primarily gray matter in
term infants and white matter in prematures. This selec-
tive vulnerability of different cellular populations is
related to maturational events connected to cerebral
vascular system development. The neonatal encephalic
regions that are more exposed to the risk of ischemia
are those localized in the border zones between the
end-fields of the major cerebral arteries (anterior, mid-
dle and posterior), where normal perfusion rate is basi-
cally low for the absence of anastomotic connections
[15]. These border zones, in fact, according to watershed
concept (Volpe JJ, 2008) are the brain areas most sus-
ceptible to a fall in cerebral perfusion pressure. The
watershed concept, based on the analogy with an irriga-
tion system supplying a series of fields with water,
emphasizes the vulnerability of the “last fields” when the
head of pressure falls and have received ample experi-
mental support in several developing animal models of
hypoxic-ischemic cerebral damage [16].
In term infants, hypoperfused areas are localized
superficially in the parasagittal cerebral regions, with
ischemic injuries interesting cortical gray matter and
adjacent layers of subcortical white matter. The charac-
teristic neuropathologic aspects are represented by corti-
cal laminar necrosis with subcortical leukomalacia.
In preterm infants, hypoperfused areas involve periven-
tricular white matter regions. Therefore, in these subjects
the classical neuropathologic aspect is that of periventri-
cular leukomalacia (PVL), where damaged cells are made
up of immature oligodendrocytes or premyelinating
oligodendrocytes (pre-OLs) that ensheath axons in pre-
paration for full differentiation to myelin-producing oli-
godendrocytes [17]. In preterm newborns, in addition to
the peculiarity of periventricular arterial vascularisation,
PVL is also favoured by other factors related to prema-
turity such as metabolic hyperactivity of periventricular
encephalic areas - where intense processes of prolifera-
tion, differentiation and migration of glial and neuronal
cells occur, raising oxygen and nutrients demand -
and, above all, the particular vulnerability of immature
oligodendrocytes to the oxidative stress due to their poor
content of anti-oxidizing enzymes [18,19]. Another
important role is played by the lack of neuroprotective
factors such as neurotrophines and oligotrophines that
are trophic substances capable of supporting brain devel-
opment and inhibiting apoptotic phenomena. In the first
phases of pregnancy, these factors are produced by the
mother and reach the fetus through the placenta, whereas
at the end of the pregnancy they are synthesized by the
same fetus. Availability of s u c hf a c t o r si st h e r e f o r e
strongly deficient in preterm infants, especially in highly
premature ones [16,20,21].
Figure 1 Pathogenesis of hypoxic-ischemic cerebral damage: potential sequences of events developing during ischemic phase (Phase 1).
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From a pathological point of view, PVL can be distin-
guished in two forms: focal and diffuse. The focal form
is less frequent and related to severe H-I insults. This
form involves deep layers of white matter surrounding
long penetrating arteries terminations and is character-
ized by macro or microscopic necrotic foci - where
destruction of all cellular elements and axonal distrup-
tion occur - respectively evolving, over several weeks, to
multiple cysts (easily visible to cranial ultrasonography)
and to glial scars [22]. The neuropathological sequelae
of focal necrotic lesions are correlated with cerebral
palsy (spastic diplegia) that affects 5-10% of very low
birth weight infants with PVL [18].
The most frequent diffuse form is related to moderate
H-I insult and occurs in central white matter areas sup-
plied by terminations of penetrating short arteries. It
consists of diffuse processes of astrogliosis and micro-
gliosis associated to pre-OLs loss [23,24]. This later
form is undistinguishable from cranial ultrasonography,
appearing as a not specific diffuse periventricular hyper-
echogenicity that can be identified by DW and DT MRI
[25] and it is clinically correlated to cognitive behavioral
deficits affecting 25-50% of PVL cases [18]. In the
pathogenesis of diffuse PVL an important role is played
by the activation of microglia, a cerebral supporting
structure constituted by immunocells with macrophagic
function present in large numbers in the developing
periventricular white matter [26] (Figure 3). Such activa-
tion is associated with the release of nitric oxide,
free radicals, glutamate and cytokines, substances able
to induce pre-OLs death. Because of the lack of anti-
oxidizing defences and the exuberant expression of
glutamatergic and cytokinic receptors, these cells are
particularly sensible to oxidative, excytotoxic and
inflammatory injuries [27,28]. The susceptibility of these
cellular elements to oxidative stress is also increased by
their high content of free iron, a molecule indispensable
for differentiation in mature oligodendrocytes, and by
the presence of nitric oxide, that favour the formation
of extremely reactive oxygen and nitrogen radicals. In
diffuse PVL, pre-OLs damage causes a maturative deficit
of oligodendroglia with subsequent dysfunction or loss
of actively myelinating OLs impairing nervous fibres
myelination and reducing cerebral white matter with
appearance of ventriculomegaly (Figure 4).
Figure 2 Pathogenesis of hypoxic-ischemic cerebral damage: potential sequences of events developing during ischemia reperfusion
(Phase 2).
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As white matter contains both oligodendroglial and axo-
nal components it is still not clear whether, in diffuse
PVL, H-I injuries involve only the oligodendrocytes or
also the axons. While axonal damage has long been
recognized as a classic feature of focal necrotic lesions
[29,30], observations of axonal injuries are only frag-
mentary in the diffuse form of PVL [31]. Moreover, in a
recent study on fractin, a biochemical marker of apopto-
sis, Haynes et al. demonstrated the presence of wide-
spread axonal damage in non-necrotic PVL contributing
to reduced white matter volume revealed by volumetric
MRI in long term survivors [32]. The cause of these
axonal alterations is not yet clear, but it is probably sec-
ondary to oligodendroglial injuries. Myelinating oligo-
dendrocytes play a critical trophic role in axonal
development, survival and function, given the important
effects of myelin-related proteins and OL-specific signals
in long-term viability, thickness and conduction of
axons [33,34]. Therefore by compromising neurotrophic
factors release, pre-OLs loss can induce failure of axonal
development and/or axonal degeneration that involving,
through retrograde and anterograde trans-synaptic
effects, cortical-thalamic projection, commissural and
association fibres lead to volume reduction of cerebral
cortex and thalamus [35]. This is mainly due to the fact
that axonal alterations affect “subplate neurons”, a tran-
sient population of neurons that are abundant in cere-
bral white matter, reach a maximum during the peak
period for the occurrence of PVL (24-32 weeks of gesta-
tion) and play a crucial role in the development of the
thalamus and brain cortex [36-38] (Figure 4). Volu-
metric MRI analyses of preterm infants with diffuse
PVL, at term-equivalent age or older, have shown that,
besides cortex and thalamus, volume reduction can
involve other neuronal structures such as basal ganglia,
cerebellum and brain stem [39,40]. Recent neuropatho-
logical studies showed that volumetric reduction of
these structures was consistent with the finding of neu-
ronal loss and gliotic processes [22,41]. These observa-
tions postulate the presence of a more complex
“neuronal/axonal disease” accompanying oligodendro-
glial lesions in diffuse PVL. Therefore, the previously
reported widespread axonopathy observed in non-necro-
tic PVL could be, to some extent, expression of degen-
erative processes secondary to primitive death of
neuronal cell bodies in the gray matter of cortical and
subcortical structures (especially the thalamus whose
axons project to and from the cerebral cortex). Axonal
impairment is suggested by NMR studies utilizing DTI
Figure 3 Pathogenesis of periventricular leukomalacia. Role of microglia activation.
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non cystic PVL, as early as term equivalent age, showed
a diminished relative anisotropy, an MRI measure of
preferred directionality of diffusion [42,43].
As reported in several studies in literature, brain
damage in HIE can be detected by serum dosage of
some biochemical markers of cerebral hypoxia, such as
adrenomedullin, protein S-100B, Activin A [44-48].
Recently, the coexistence of neuro-axonal and glial
alterations in PVL have been documented by our group
studying serial serum levels of neuron-specific enolase
(NSE) and protein S-100 (PS-100) in the first week of
life, as biochemical markers of brain hypoxic injuries
involving respectively gray and white matter. In thirty
premature infants with perinatal asphyxia (severe in 15
cases and moderate in 15 cases) and neurosonographic
findings suggesting diffuse white matter injury (periven-
tricular echodensities/echolucences) or cystic PVL, NSE
and PS-100 mean serum levels, at 3,24,48 hours and 7
days of life, were significantly elevated at all the time
intervals compared to control group, the highest values
being observed in the group of neonates with severe
asphyxia. In these severely asphyxiated neonates, NSE
values decreased constantly from birth to the seventh
day of life, while PS-100 increased progressively over the
7 days [49] (Figure 5).
Neurogenetic and gliogenetic processes after H-I
injury
Recent studies in brains damaged by H-I insult have
demonstrated that some cellular mechanisms can be
activated in order to repair cerebral injuries [17]. These
mechanisms involve the neural stem/progenitor cells
(NSPS) normally resident in the subventricular zone
(SVZ) of the mammalian brain that can be stimulated
by hypoxia-ischemia to proliferate and differentiate into
both neurons and oligodendrocytes. Yang et al have
observed that H-I insult expanded the regenerative
capacity of NSPs in the SVZ of the injured hemisphere
in a neonatal rat model of H-I cerebral injury produced
by unilateral common carotid artery ligation [50]. This
robust proliferative response of SVZ-progenitors was
accompanied by their capacity to differentiate into neu-
ronal and glial elements, to migrate from the ipsilateral
SVZ and to colonize the damaged structures (Figure 6).
These observations raise the interesting possibility that
these new cells may play an important role in repairing
neuronal and glial losses related to HIE. Therefore,
NSPS in SVZ could be a valuable target for therapeutic
strategies to enhance recovery after cerebral H-I injury.
In this field of researches related to the possibility of
repairing damaged cerebral structures, studies utilizing
some pluripotent cells discovered in the stroma of
Figure 4 Consequences of pre-oligodendrocytes loss in diffuse PVL.
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humans are intriguing. These adipose stromal cells
(ASC) can exhibit differentiation into neural and glial
elements in vivo and in vitro and are capable of secret-
ing potent neurotrophic factors [51]. In a rat middle
cerebral artery occlusion model of ischemic brain injury,
Kang et al [52] observed that intracerebral transplanta-
tion of human ASC was followed by migration of these
cells to areas of ischemic damage and by expression of
neuronal specific markers in conjunction with functional
benefit. Therefore, therapeutic ASC could be an oppor-
tunity for developing treatments that will reverse or pre-
vent the effects of H-I injury. Their clinical use,
however, is strongly limited by the existence of the
blood-brain barrier (BBB) that makes the human brain
refractory to targeting of cell-sized agents delivered
through the peripheral system. As intracerebral trans-
plantation for bypassing BBB is a very invasive delivery
method that cannot be proposed for human newborns,
recently Wei et al. have designed a study to evaluate
whether the same beneficial effects against H-I brain
damage could be obtained with the neurotrophic factors
secreted by ASC during culture, delivered through the
peripheral venous system both preceding and following
H-I injury [53]. Their results, obtained in a rat model of
H-I injury, showed that infusion (1 hour before or 24
hours after injury induction) of concentrated medium
(CM) from cultured ASC (ASC-CM) significantly pro-
tected against the hippocampal and cortical volume loss
observed in controls. Moreover, analysis of parallel
groups for behavioural and learning changes at 2
months post-ischemia demonstrated that rats treated
with ASC-CM performed significantly better than con-
trols in Morris water maze functional tests commonly
used for studying spatial learning in the rat [54]. These
positive effects of ASC-CM are not surprising because
the cultural milieu of ASC was rich in neurotrophic fac-
tors, particularly insulin like growth factor-1 (IGF-1)
a n db r a i nd e r i v e dn e u r o t r o p h i cf a c t o r( B D N F )w h i c h ,
respectively, protect against cerebral cells apoptosis and
glutamate-excitotoxicity [55-57]. In non published data,
the same authors [53] found that equal neuroprotective
activity in vitro was exhibited by ASC-CM derived from
human ASC, this suggesting its potential and positive
utilization in preventing or attenuating neonatal HIE. In
addition to beneficial effects connected to antiapoptotic
Figure 5 Neuron specific enolase (NSE) and protein S-100 (PS-100) mean serum levels at 3, 24, 48 hours and 7 days of life in preterm
infants with severe perinatal asphyxia.
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involved in the recovery of damaged tissues stimulating
migration, homing and differentiation of brain progeni-
tor cells resident in SVZ. This approach could be an
interesting way to stimulate endogenous repair without
the need for targeting donor cells to the brain. Such
hypothesis is supported by the recent discovery of some
substances, i.e. 1alpha/CXC chemokine and nerve
growth factor able to stimulate proliferation, homing
and differentiation of resident neural progenitor cells in
adults with cerebral injuries[58,59].
If all these observations are confirmed by further sys-
tematic studies in the coming years, it is possible to spec-
ulate that, intravenous delivery of the milieu of factors
secreted by ASC at 24-72 hours after H-I injury may
represent a new promising therapeutic strategy for treat-
ment of human neonatal HIE in addition to hypothermia
that, currently, represents the most efficacious option for
preventing or attenuating cerebral damage [60].
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